Haitong Chuangshi Investment Management

Haitong Chuangshi is a private equity subsidiary of Haitong Securities, one of China's largest state-licensed securities firms. It operates as a distinct investment arm, drawing on the parent's network and capital for direct private equity deals (per the firm's official communications and public record).

The firm covers a broad spectrum from early-stage seed and startup rounds through growth equity and PIPE to pre-IPO financings. Its stated strategy includes venture, growth, and late-stage investments, reflecting flexibility across a company's lifecycle (per the firm's strategy disclosure and Altss research).

Public records and the firm's strategy indicate a focus on Chinese domestic enterprises across technology, consumer, and healthcare. Specific sector exclinations are not publicly documented, but the firm's venture and growth emphasis suggests a primary orientation toward sectors with high growth potential in China.

Yes, Haitong Chuangshi Investment Management appears to be a legally separate subsidiary registered as a private equity management entity in China, distinct from Haitong Securities' main brokerage and investment banking operations. However, its governance and funding are linked to the parent, per typical Chinese financial conglomerate structures.

No publicly available data specifies the typical investment size. As a multi-stage firm, check sizes likely vary widely from small seed tickets to larger growth and PIPE commitments, depending on the stage and opportunity.